Nevertheless, to confirm the finding that FASN and HER2 expressions were correlated in ovarian cancer, patients were divided into high expression of FASH (high)/HER2 (high) and FASN (high)/HER2 (Low) group (Fig. 4). This evidence concerns the gene FASN and ovarian carcinoma.